🇺🇸 FDA
Patent

US 11354990

Treatment of kidney diseases associated with elevated AVP

granted A61KA61K31/4365A61K31/519

Quick answer

US patent 11354990 (Treatment of kidney diseases associated with elevated AVP) held by United States Government as represented by the Department of Veterans Affairs expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4365, A61K31/519, A61K31/55, A61K38/095